Corcept Therapeutics Incorporated (CORT)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 10,882 | 6,481 | 5,385 | 5,281 | 5,582 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $10,882K ÷ $—K
= —
The payables turnover ratio for Corcept Therapeutics Incorporated is not available for the years 2020 to 2024. The absence of data on payables turnover indicates a lack of insight into how efficient the company is at managing its accounts payable in relation to its cost of goods sold. A higher payables turnover ratio typically suggests that a company is paying its suppliers more quickly, which can be an indication of strong cash flow management. Without this ratio, it is challenging to assess the company's ability to effectively utilize its accounts payable to support its operations or financial health.
Peer comparison
Dec 31, 2024